55 results
424B3
ALIM
Alimera Sciences Inc.
12 Jul 23
Prospectus supplement
12:00am
, subject to applicable community property laws.
Beneficial OwnershipBefore the Offering
Maximum Number of Shares that may be Offered and Sold
8-K
EX-2.1
bwqdgs l6hebv9rm0qyv
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
iacsr9g61bi5m31
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
qhdwu2z08lge sdwo6tc
1 Dec 21
Alimera Sciences Welcomes Ophthalmic Strategic Consultant
8:27am
424B5
fhbo2 mqy1p
28 Nov 14
Prospectus supplement for primary offering
12:00am